September 2025 Content Release Copied
Clinical Profile Documentation
Additions
The Problems > Add Details area is updated with applicable documentation points for the following diagnoses.
CDK4 amplification status is now available for Uterine Cancer, Sarcoma (Parent) with the following documentation points:
- Positive
- Negative
- Other non-actionable finding
- Unknown
PD-L1 Tumor Area Positivity (TAP) status is now available for Esophageal Cancer (Parent) and Gastric Cancer with the following documentation points:
- TAP >/=1%
- TAP <1%
- Unknown
HER2 and PR status now auto populates their respective ICD-10-CM code:
- PR Status Positive generates the following additional code: Z17.21 – Progesterone receptor positive status
- PR Status Negative generates the following additional code: Z17.22 – Progesterone receptor negative status
- HER2 Status Positive generates the following additional code: Z17.31 – Human epidermal growth factor receptor 2 positive status
- HER2 Status Negative generates the following additional code: Z17.31 – Human epidermal growth factor receptor 2 negative status
Updates
Connect on HER2 LOW and ULTRA LOW Testing with Dr. Balanchivadze is no longer available for Breast Cancer.
c-Met overexpression status has been updated to c-Met overexpression by IHC for Lung Cancer, Non-small Cell (NSCLC).
AJCC Version 9 Staging
This release contains updated TNM values, Staging Groups, and Template functionality to align with AJCC version 9 conditions for:
- Thymoma Malignant
- Diffuse Pleural Mesothelioma
Users will see updated values and descriptions for Primary Tumor Type (T), Regional Lymph Nodes (N), and Distance Metastasis (M) documentation points for Thymoma Malignant.
The following documentation points now have updated descriptions:
| T Value | Description |
| cT0 | No evidence of primary tumor |
| cT1 | Tumor limited to the thymus with or without encapsulation, or directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| cT1a | Tumor <= 5 cm in greatest dimension with either: limited to the thymus with or without encapsulation, directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| cT1b | Tumor > 5 cm in greatest dimension with either: limited to the thymus with or without encapsulation, directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| cT2 | Tumor with direct invasion of the pericardium (either partial or full thickness), or the lung, or the phrenic nerve |
| cT3 | Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins |
| cT4 | Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery or veins, myocardium, trachea, esophagus |
| cTX | Primary tumor cannot be assessed |
| pT0 | No evidence of primary tumor |
| pT1 | Tumor limited to the thymus with or without encapsulation, or directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| pT1a | Tumor <= 5 cm in greatest dimension with either: limited to the thymus with or without encapsulation, directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| pT1b | Tumor > 5 cm in greatest dimension with either: limited to the thymus with or without encapsulation, directly invades into the mediastinal fat only, or directly invades the mediastinal pleura but does not involve any other mediastinal structure |
| pT2 | Tumor with direct invasion of the pericardium (either partial or full thickness), or the lung, or the phrenic nerve |
| pT3 | Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins |
| pT4 | Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus |
| pTX | Primary tumor cannot be assessed |
| N Value | Description |
| cN0 | No tumor involvement of regional lymph node(s) |
| cN1 | Tumor involvement of anterior (perithymic) lymph nodes |
| cN2 | Tumor involvement of deep intrathoracic or cervical lymph nodes (e.g., paratracheal, subcarinal, aortopulmonary window, hilar, jugular, and/or supraclavicular nodes) |
| cNX | Regional lymph nodes cannot be assessed |
| pN0 | No tumor involvement of regional lymph node(s) |
| pN1 | Tumor involvement of anterior (perithymic) lymph nodes |
| pN2 | Tumor involvement of deep intrathoracic or cervical lymph nodes (e.g., paratracheal, subcarinal, aortopulmonary window, hilar, jugular, and/or supraclavicular nodes) |
| pNX | Regional lymph nodes cannot be assessed |
| M Value | Description |
| cM0 | No pleural, pericardial, or distant metastasis |
| cM1 | Distant metastasis |
| cM1a | Separate pleural or pericardial nodule(s) |
| cM1b | Pulmonary intraparenchymal nodule or other distant metastasis |
| pM1 | Microscopic confirmation of distant metastasis |
| pM1a | Microscopic confirmation of separate pleural or pericardial nodule(s) |
| pM1b | Microscopic confirmation of pulmonary intraparenchymal nodule or other distant metastasis |
Users will see updated values and descriptions for Primary Tumor Type (T), Regional Lymph Nodes (N), and Distance Metastasis (M) documentation points for Diffuse Pleural Mesothelioma.
The following documentation points now have updated descriptions:
| T Value | Description |
| cT0 | No evidence of primary tumor |
| cT1 | Tumor limited to the ipsilateral pleura with Psum <= 12 mm and no involvement of the fissure (Fmax <= 5 mm) |
| cT2 | Tumor involving the ipsilateral pleura with Psum <= 12 mm, and with any of the following: involvement of the fissure (Fmax > 5 mm), mediastinal fat invasion, or solitary area of chest wall soft tissue invasion OR tumor involving the ipsilateral pleura with Psum > 12 mm but <= 30 mm, with or without: involvement of the fissure (Fmax > 5 mm), mediastinal fat invasion, or solitary area of chest wall soft tissue invasion |
| cT3 | Tumor involving the ipsilateral pleura with Psum > 30 mm, with or without: involvement of the fissure (Fmax > 5 mm), mediastinal fat invasion or solitary area of chest wall soft tissue invasion |
| cT4 | Tumor with invasion of any of the following (any Psum): chest wall bony invasion (rib), mediastinal organs (heart, spine, esophagus, trachea, great vessels), diffuse chest wall invasion, direct tumor extension through the diaphragm or pericardium, direct extension to the contralateral pleura, or presence of malignant pericardial effusion |
| cTX | Primary tumor cannot be assessed |
| pT0 | No evidence of primary tumor |
| pT1 | Primary tumor cannot be assessed |
| pT2 | Tumor limited to the ipsilateral pleura with no involvement of the fissure |
| pT3 | Tumor limited to the ipsilateral pleura (with or without fissure involvement) and with invasion of any of the following: mediastinal fat, surface of pericardium, endothoracic fascia, or solitary area of chest wall soft tissue |
| pT4 | Tumor with invasion of any of the following: chest wall bony invasion (rib), mediastinal organs (heart, spine, esophagus, trachea, great vessels), diffuse chest wall invasion, transmural invasion of the diaphragm or pericardium, direct extension to the contralateral pleura, presence of malignant pericardial effusion |
| pTX | Primary tumor cannot be assessed |
| N Value | Description |
| N0 | No tumor involvement of regional lymph node(s) |
| N1 | Tumor involvement of ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal lymph nodes) regional lymph nodes |
| N2 | Tumor involvement of contralateral mediastinal, ipsilateral or contralateral supraclavicular lymph nodes |
| NX | Regional lymph nodes cannot be assessed |
| M Value | Description |
| cM0 | No distant metastasis |
| cM1 | Distant metastasis |
| pM1 | Microscopic confirmation of distant metastasis |
The staging calculator will display updated Stage values based on the changes to the staging groups. The new content does not affect previous charting documented on existing patients. A summary table is provided below.
All previous charting is brought forward during a subsequent visit, just as it did prior to this release.
| Tumor Type | Node | Metastasis | Stage | ||
| cT1 | N0 | cM0 | I | ||
| pT1 | N0 | cM0 | I | ||
| cT2 | N0 | cM0 | II | ||
| pT2 | N0 | cM0 | II | ||
| cT1 | N1 | cM0 | II | ||
| pT1 | N1 | cM0 | II | ||
| cT2 | N1 | cM0 | IIIA | ||
| pT2 | N1 | cM0 | IIIA | ||
| cT3 | N0 | cM0 | IIIA | ||
| pT3 | N0 | cM0 | IIIA | ||
| cT3 | N1 | cM0 | IIIA | ||
| pT3 | N1 | cM0 | IIIA | ||
| cT1 | N2 | cM0 | IIIA | ||
| pT1 | N2 | cM0 | IIIA | ||
| cT2 | N2 | cM0 | IIIA | ||
| pT2 | N2 | cM0 | IIIA | ||
| cT3 | N2 | cM0 | IIIA | ||
| pT3 | N2 | cM0 | IIIA | ||
| cT4 | Any N | cM0 | IIIB | ||
| pT4 | Any N | cM0 | IIIB | ||
Problems
Additions
New items are available for documentation in Problems and appear in the Charge Capture Report (CCR). Additional ICD-10 codes* may be displayed to present the surrounding nodes.
Please see Appendix A for a complete summary of changes.
Lab Analytes & Panels
Additions/Updates
- Adenylate kinase, B, U/g Hb
- Ammonium, 24 hour urine, mEq/24hr
- Citric acid, 24 hour urine, mg/24hr
- Comprehensive hemeSEQ panel result
- Cortisol, baseline pre-cortrosyn panel
- Cortisol, baseline pre-cortrosyn, ug/dL
- Dihydrolipoamide dehydrogenase(DDL) deficiency additional information
- Dihydrolipoamide dehydrogenase(DDL) deficiency interpretation
- Dihydrolipoamide dehydrogenase(DDL) deficiency result
- Dihydrolipoamide dehydrogenase(DDL) deficiency reviewer
- FoundationOne germline more panel
- Glutathione B, mg/dL
- HB stability, B
- Insulin, mIU/mL
- Invitae hereditary colorectal cancer guidelines-based panel
- Invitae methylmalonic acidemia and homocystinuria panel
- Oncotype DX breast recurrence score test
- Parvovirus B19 DNA, qn real time PCR, Log copies/mL
- Phosphofructokinase, B, U/g Hb
- Phosphoglycerate kinase, B, U/g Hb
- TCRG pathologist interpretation
- Tempus CancerNext/Cancer Next expanded DNA + RNA kit panel
- Tempus CancerNext/Cancer Next expanded DNA only kit panel
- Tempus xM tissue-free kit panel
- Tempus xT normal match, xF/xF+ liquid biopsy kit panel
- Triosephosphate isomerase, B, U/g Hb
- Vancomycin, peak, mg/L
- Vitamin D, 25-hydroxy, total panel
Medications
Additions
- Sacituzumab govitecan invest IV
- UTD1 invest (Utidelone invest IV)
- Utidelone invest IV
- YL205 invest IV
Updates
| Medications | Updates |
| ABBV-101 invest Oral | New Form available:
|
| BAK Topical Cream (Baclofen 1% or 2%, Amitriptyline 2%-10%, Ketamine 5%-10%, compounded in lipoderm base) | New Medication Name:
New General Instructions:
|
| BBO-11818 invest Oral | New Form available:
|
| BNT324/DB-1311 invest IV | Updated Name to:
Removed Instructions
Removed SIGs:
|
| Cytarabine (PF) Intrathecal | New Flat Dose Unit available:
|
| Dasatinib Oral | Instructions removed:
|
| DB-1311 invest IV | New Form available:
SIG removed:
SIG available:
|
| IBI363 invest IV | Instructions removed:
New SIG available:
|
| LOXO-435 invest Oral | New Form available:
|
| Petosemtamab invest IV | New Medication Name:
New Alias available:
New Form available:
|
| TORL-1-23 invest Oral | SIG removed:
|
| TORL-3-600 invest IV | SIG removed:
|
| Zanubrutinib Oral | Default Form is set to:
Note: G2 software defaults the Unit to tablet, even though the SIG is 160 mg and the form is 80 mg capsule. CIS cannot override this, and no Unit: capsule is available. Please manually change the Unit to capsule when ordering. |
| Zanzalitinib invest (XL-092 invest Oral) | New Forms available:
New Quick SIG Pick available:
SIG removed:
|
| Zongertinib Oral | New Max Single Dose available:
New Quick SIG Pick available:
|
Regimen Library
Additions
| Regimen Name | Diagnosis |
| Capecitabine D1-14 + Oxaliplatin (XELOX/CAPOX) + Atezolizumab IV Q21D | Colon Cancer; Rectal Cancer |
| Capecitabine D1-14 + Oxaliplatin (XELOX/CAPOX) + Atezolizumab SQ Q21D | Colon Cancer; Rectal Cancer |
| Cosibelimab-ipdl Q21D | Cutaneous Carcinoma, Squamous Cell |
| Fluorouracil (CIV) D1,15 + Oxaliplatin D1,15 + Docetaxel D1,15 + Durvalumab (FLOT Perioperative) fb Durvalumab Q28D | Esophageal Cancer (Parent); Gastric Cancer |
| Influenza Vaccines 2025-2026 | All Problems |
| Methotrexate D1, 8, 15, 22 + Prednisone Q28D | |
| Modified R-CODOX-M alternating with R-IVAC Q28D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
| Zongertinib Q30D |
Updates
Biosimilar Precheck Changes
The iKnowMed regimen updates for the top 130 utilized biosimilar regimens will be active with the September Content Release. The remaining regimens are scheduled to be updated with the October iKnowMed content release.
- Nyvepria® will be replaced with Fulphila®
- Ruxience® will be replaced with Truxima®
- Trazimera® will be replaced with Ogivri®
- Zirabev® will be replaced with Vegzelma®
Vaccines
- Updated for the 2025-2026 season:
- Influenza Vaccines 2025-2026
- Covid-19 Vaccines
- The meningococcal vaccine Bexsero will be updated from 2 doses to 3 doses to complete a primary series in vaccine regimens and complement-inhibitor regimens.
Dermatologic Prophylaxis in Amivantamab-Containing Regimens
Amivantamab is associated with a high rate of Grade 2+ skin toxicity. The COCOON study demonstrated that enhanced dermatologic prophylaxis may reduce rash and paronychia. Amivantamab-containing regimens will be updated in the September release to include pre-checked orders for oral doxycycline, clindamycin lotion, chlorhexidine topical liquid, and ceramide-based moisturizer. A standalone EGFR Dermatologic Prophylaxis supportive care regimen will be made available in the October release.
Regimens for the following diagnoses have been updated based on the Collaborative Care Committee voting. Changes include but are not limited to reference update, drug infusion instruction updates, renaming of regimens, premedication template updates and number of cycles.
- All Problems
- Bile Duct Cancer (Parent)
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colon Cancer
- Esophageal Cancer (Parent),
- Fallopian Tube Cancer
- Gallbladder Cancer
- Gastric Cancer
- Head and Neck Cancer (Parent)
- Hemolytic Uremic Syndrome
- Leukemia, Acute Lymphocytic (ALL)
- Lung Cancer, Non-small Cell (NSCLC)
- Lung Cancer, Small Cell (SCLC)
- Lymphoma, Hodgkin (HL)
- Lymphoma, Non-Hodgkin (NHL) (Parent)
- Myasthenia Gravis
- Ovarian and Primary Peritoneal Cancer
- Paroxysmal Nocturnal Hemoglobinuria
- Prostate Cancer
- Rectal Cancer
- Renal Cell Carcinoma (RCC)
- Renal Pelvis and Ureter Cancer
- Sarcoma, Bone (Parent)
- Sarcoma, Soft Tissue (Parent)
- Testicular Cancer (Parent)
- Thyroid Cancer (Parent)
- Urethral Cancer
- Uterine Cancer (Parent)
Renames
| Previous Name | New Name |
| Lenvatinib Q30D (Thyroid, Uterine) | Lenvatinib Q30D (Thyroid, Uterine, RCC) |
| Mirvetuximab soravtansine-gynx + Bevacizumab Q21D | Mirvetuximab soravtansine-gynx (Elahere) + Bevacizumab Q21D |
Billing & HCPCS Codes
Updates
The September 2025 updates include new HCPCS Level II codes to separately identify products approved under the 505(b)(2) New Drug Application (NDA) or the Biologics License Applications (BLA) pathways after October 2003 and not rated as therapeutically equivalent to a reference listed product in an existing code. A complete application summary and coding link can be found on the HCPCS Level II Coding Decisions page.
Please visit the CMS website for a complete list of October 2025 HCPCS Quarterly update.
The following products have not been released per First Databank (FDB):
- J0462 – Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
- Q5154 – Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
- Q5155 – Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
- Q5156 – Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
- Q5159 – Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
Additions
| Medication | HCPCS Codes |
| Arginine IV | J3490 per 200 mg |
| Bevacizumab-nwgd IV | J3590 per 700 mg |
| Bivalirudin IV | J3490 per 250 mg |
| Carboplatin IV | J9999 per 1 mg |
| Cefotetan IM | J3490 per 1 gm |
| Cefotetan IV | J3490 per 1 gm |
| COVID vaccine (Moderna) (PF) IM (6 months thru 11 yrs) | 91321 per 0.25 mL |
| COVID vaccine (Pfizer) (PF) IM (5 yrs thru 11 yrs) | 91319 per 0.3 mL |
| Denosumab-bmwo Subcutaneous (120 mg/1.7 mL – Osenvelt) | J3590 per 120 mg |
| Denosumab-bmwo Subcutaneous (60 mg/mL – Stoboclo) | J3590 per 60 mg |
| Denosumab-bnht Subcutaneous (120 mg/1.7 mL – Bomyntra) | J3590 per 120 mg |
| Denosumab-bnht Subcutaneous (60 mg/mL – Conexxence) | J3590 per 60 mg |
| Donidalorsen Subcutaneous Auto-Injector | J3490 per 80 mg |
| Ethacrynate IV | J3490 per 9.5 mg |
| Fitusiran Subcutaneous | J3490 per 20 mg |
| Fitusiran Subcutaneous Pen Injector | J3490 per 50 mg |
| Fluorescein IV 10 % | J3490 per 500 mg |
| Fosdenopterin IV | J3490 per 9.5 mg |
| Remestemcel-L-rknd IV | J3590 per 2 x 10e6 MSCs |
| Semaglutide Subcutaneous Pen Injector | J3490 per 0.25 mg |
| Treosulfan IV | J9999 per 10 g |
The following HCPCS codes will be effective October 1, 2025.
| Medication | HCPCS Codes |
| Aztreonam-avibactam IV 2 gram | J0458 per 10 mg |
| Bivalirudin IV | J0582 per 1 mg |
| Bupivacaine-Meloxicam Instillation ER Solution 200 mg-6 mg/7 mL | J0668 per 0.03 mg |
| Bupivacaine-Meloxicam Instillation ER Solution 400 mg-12 mg/14 mL | J0668 per 0.03 mg |
| Carboprost IM | J0675 per 0.1 mg |
| Carboprost Intramyometrial | J0675 per 0.1 mg |
| Carboprost Intravesical | J0675 per 0.1 mg |
| Cefotetan IM | J0525 per:
|
| Cefotetan IV | J0525 per:
|
| Ceftobiprole IV | J0681 per 3 mg |
| Clevidipine Continuous IV Infusion | J0759 per:
|
| Concizumab-mtci Subcutaneous Pen Injector | J7173 per 0.5 mg |
| Datopotamab deruxtecan-dlnk IV | J9011 per 1 mg |
| Denosumab-bmwo Subcutaneous (120 mg/1.7 mL – Osenvelt) | Q5157 per 1 mg |
| Denosumab-bmwo Subcutaneous (60 mg/mL – Stoboclo) | Q5157 per 1 mg |
| Denosumab-bnht Subcutaneous (120 mg/1.7 mL – Bomyntra) | Q5158 per 1 mg |
| Denosumab-bnht Subcutaneous (60 mg/mL – Conexxence) | Q5158 per 1 mg |
| Epinephrine Continuous Intraosseous Infusion | J0163 per 0.1 mg J0164 per 0.1 mg |
| Epinephrine Intra-Arterial | J0163 per 0.1 mg J0164 per 0.1 mg |
| Epinephrine Intraosseous | J0163 per 0.1 mg J0164 per 0.1 mg |
| Epinephrine IV | J0163 per 0.1 mg J0164 per 0.1 mg |
| Esomeprazole IV | J1370 per 1 mg |
| Ethacrynate IV | J1807 per 1 mg |
| Fitusiran Subcutaneous | J7174 per 0.04 mg |
| Fitusiran Subcutaneous Pen Injector | J7174 per 0.04 mg |
| Fluorescein IV 10 % | A9612 per 1 mg |
| Fluorescein IV 25 % | A9612 per 1 mg |
| Fluorescein Oral | A9612 per 1 mg |
| Fosdenopterin IV | J1809 per 0.1 mg |
| Glucagon IV | J1612 per:
|
| Isoniazid IM | J1834 per 1 mg |
| Kit for Prep of Ga 68-Gozetotide IV | A9616 per:
|
| Lenacapavir Oral | J0752 per 300 mg |
| Lenacapavir Subcutaneous | J0738 per 1 mg |
| Lenacapavir via feeding tube | J0752 per 300 mg |
| Mannitol IV 10 % | J2151 per:
|
| Mannitol IV 15 % | J2151 per 250 mg |
| Mannitol IV 20 % | J2151 per:
|
| Mannitol IV 25 % | J2151 per:
|
| Mannitol IV 5 % | J2151 per 250 mg |
| Nafcillin IV | J2291 per:
|
| Remestemcel-L-rknd IV | J3402 per:
|
| Revakinagene taroretcel-lwey Intravitreal 200,000 to 440,000 cell | J3403 per implant |
| Tranexamic Acid Inhalation | J3290 per 5 mg |
| Tranexamic Acid Irrigation | J3290 per 5 mg |
| Tranexamic Acid IV | J3290 per:
|
| Tranexamic Acid Oral | J3290 per 5 mg |
| Tranexamic Acid Topical | J3290 per 5 mg |
| Treosulfan IV | J0614 per:
|
Removals
The following HCPCS codes will be discontinued on September 30, 2025.
| Medication | HCPCS Codes |
| Mannitol IV 10 % | J2150 per:
|
| Mannitol IV 15 % | J2150 per 50 mL |
| Mannitol IV 20 % | J2150 per:
|
| Mannitol IV 25 % | J2150 per:
|
| Mannitol IV 5 % | J2150 per 50 mL |
| Pegaptanib Intravitreal | J2503 per 0.3 mg |
NDC – HCPCS Crosswalk
Updates
The CMS ASP pricing can be found on the CMS website.
Additions
| Medication (Brand) | HCPCS Codes | NDC |
| Bivalirudin IV (Endo) | J0582 per 1 mg | 42023062201 42023062210 70860040350 70860040351 |
| Denosumab-bmwo Subcutaneous (120 mg/1.7 mL – Osenvelt) | Q5157 per 1 mg | 72606003801 |
| Denosumab-bmwo Subcutaneous (60 mg/mL – Stoboclo) | Q5157 per 1 mg | 72606003701 |
| Denosumab-bnht Subcutaneous (120 mg/1.7 mL – Bomyntra) | Q5158 per 1 mg | 65219067001 65219067201 |
| Denosumab-bnht Subcutaneous (60 mg/mL – Conexxence) | Q5158 per 1 mg | 65219066801 |
| Epinephrine Continuous Intraosseous Infusion (Endo) | J0163 per 0.1 mg | 42023027301 42023027310 42023031501 42023031510 42023043401 42023043410 42023050001 42023050010 42023072101 42023072110 |
| Epinephrine Continuous Intraosseous Infusion (Baxter) | J0164 per 0.1 mg | 00338002420 |
| Epinephrine Intra-Arterial (Endo) | J0163 per 0.1 mg | 42023027301 42023027310 42023031501 42023031510 42023043401 42023043410 42023050001 42023050010 42023072101 42023072110 |
| Epinephrine Intra-Arterial (Baxter) | J0164 per 0.1 mg | 00338002420 |
| Epinephrine Intraosseous (Endo) | J0163 per 0.1 mg | 42023027301 42023027310 42023031501 42023031510 42023043401 42023043410 42023050001 42023050010 42023072101 42023072110 |
| Epinephrine Intraosseous (Baxter) | J0164 per 0.1 mg | 00338002420 |
| Epinephrine IV (Endo) | J0163 per 0.1 mg | 42023027301 42023027310 42023031501 42023031510 42023043401 42023043410 42023050001 42023050010 42023072101 42023072110 |
| Epinephrine IV (Baxter) | J0164 per 0.1 mg | 00338002420 |
| Glucagon IV (Gvoke) | J1612 per 0.01 mg | 00517290101 00517290110 |
| Kit for Prep of Ga 68-Gozetotide IV (Gozellix) | A9616 per 1 mCi | 84552050025 84552050064 |
| Nafcillin IV (Baxter) | J2291 per 20 mg | 00338101741 00338101948 |
Appendix A
Problem & Codes Summary
Detailed ICD-10 updates can be found at https://www.cms.gov/medicare/coding-billing/icd-10-codes.
Additions
| Problem | ICD-10 Codes |
| Leukocyte adhesion deficiency |
|
| Primary malignant neoplasm of breast |
|
Deletions
The following problem to ICD-10-CM mappings will NOT be available in the Clinical Profile, Problems area of iKnowMed. These ICD-10-CM codes are deletions, as of Sept. 30, 2025.
| Problem | ICD-10 Codes |
| Allergy to dairy food |
|
| Bankruptcy |
|
| Pelvic and perineal pain |
|
Invalidated
The following problem to ICD-10-CM mappings will NOT be available in the Clinical Profile, Problems area of iKnowMed. These ICD-10-CM codes are invalid, as of Sept. 30, 2025.
| Problem | ICD-10 Codes |
| Adverse reaction caused by food |
|
| Contusion of abdominal wall |
|
| Egg white-induced anaphylaxis |
|
| Food anaphylaxis |
|
Mappings
The following ICD-10-CM to problem mappings are now available in the Clinical Profile, Problems area of iKnowMed. These ICD-10-CM codes and problem mappings are valid, as of Oct. 1, 2025.
| Problem | ICD-10 Codes |
| Primary malignant neoplasm of breast |
|
Problem (SNOMED) Summary
Removals
The standard body has retired the following concepts. Where applicable, a replacement concept has been provided.
| Retired SNOMED Concept ID Description | Replaced by Description |
| 14q32 deletion syndrome | N/A |
| 3q26q27 microdeletion syndrome | 3q26q28 deletion syndrome |
| 3q27.3 microdeletion syndrome | 3q26q28 deletion syndrome |
| 5-azacytidine | N/A |
| A sore at urethral meatus | N/A |
| Ability to rise to feet | N/A |
| Ability to sit on toilet | N/A |
| Able to sit on toilet | N/A |
| Abnormal cation transport syndrome | N/A |
| Abnormal patient reaction | N/A |
| Abnormally formed tooth | N/A |
| Abrasion of pelvic region | N/A |
| Absent pulmonary trunk | N/A |
| Abuses volatile solvents | N/A |
| Accidental poisoning by disinfectant | Accidental poisoning caused by antiseptic and/or disinfectant |
| Acinetobacter grimontii | N/A |
| Acquired unequal leg length | N/A |
| Acute hepatitis B with delta-agent (coinfection) without hepatic coma | Acute hepatitis B with hepatitis D |
| Acute inflammatory demyelinating polyneuropathy | N/A |
| Acute nontraumatic subdural hemorrhage | N/A |
| Administration by chaplain of last rites to dying patient | Administration of last rites |
| Adult child of alcoholic | N/A |
| Adverse reaction to antidiabetic drug | N/A |
| Adverse reaction to biguanide oral hypoglycemic agent | Adverse reaction to biguanide hypoglycemic agent |
| Adverse reaction to paratyphoid vaccine | Adverse reaction to typhoid vaccine |
| Aeromonas salmonicida pectinolytica | N/A |
| Air embolism as a complication of medical care | Air embolism |
| Alcoholic husband | N/A |
| Alcoholic offspring | N/A |
| Alcoholic parent | N/A |
| Alcoholic spouse | N/A |
| Allergic contact dermatitis caused by disinfectant | Allergic contact dermatitis caused by antiseptic and/or disinfectant |
| Allergic disorder follow-up assessment | Allergic disorder monitoring |
| Allergic disorder initial assessment | Allergic disorder monitoring |
| Allergy to methadone analog | N/A |
| Allescheriosis | N/A |
| Allogeneic imperfect T-cell depleted allogeneic bone marrow transplant | Allogeneic T-cell depleted allogeneic bone marrow transplant |
| Allo-tetrahydrocortisol | N/A |
| Alpha-1-antitrypsin isoform null | N/A |
| Aluminum hydroxychloride | N/A |
| Amidine disinfectant adverse reaction | Amidine antiseptic adverse reaction |
| Ampulla coli | N/A |
| Anastomosis of intestine, large-to-anus | Anastomosis of colon to anal canal |
| Anterior acute poliomyelitis | N/A |
| Anterior chamber drainage tube | N/A |
| Anuria as a complication of care | Anuria |
| Appendiceal colic | N/A |
| Appointment canceled by patient | N/A |
| Arm length inequality | N/A |
| Aromatic amino acid decarboxylase deficiency | Aromatic L-amino acid decarboxylase deficiency disorder |
| Arrhinia with choanal atresia and microphthalmia syndrome | Hyposmia, nasal and ocular hypoplasia, hypogonadotropic hypogonadism syndrome |
| Arterial line | N/A |
| Arteritic leg ulcer | N/A |
| Arthritis of bilateral knee joints due to and following immunization | N/A |
| Arthritis of intervertebral joint due to and following immunization | N/A |
| Arthritis of joint of bilateral wrist regions due to and following immunization | N/A |
| Arthritis of joint of left wrist region due to and following immunization | N/A |
| Arthritis of joint of right wrist region due to and following immunization | N/A |
| Arthritis of joint of wrist region due to and following immunization | N/A |
| Arthritis of knee joint due to and following immunization | N/A |
| Arthritis of left knee joint due to and following immunization | N/A |
| Arthritis of right knee joint due to and following immunization | N/A |
| Arthritis/arthrosis | N/A |
| Arthropathy associated with dermatological disorder | N/A |
| Arthropathy associated with respiratory disorder | N/A |
| Arthrotomy of joint of shoulder girdle | N/A |
| Asked to come in – assessment of progress | Evaluation procedure |
| Asked to come in – investigation result | Discussion about result of investigation |
| Asked to come in – on drug trial | Clinical drug trial |
| Asked to come in – research | Clinical trial |
| Asked to sign med card – done | N/A |
| Assessment of family coping behavior | N/A |
| Assessment using Elderly Assessment System | N/A |
| Assisted living facility patient | Lives in assisted living facility |
| Asthma follow-up | Asthma monitoring |
| Attach identification bracelet to subject | Attachment of identification band to extremity |
| Auditory canaloplasty | N/A |
| Augmentative communication | Augmentative and alternative communication |
| Augmented betamethasone dipropionate | Betamethasone dipropionate |
| Autosomal dominant Charcot-Marie-Tooth disease type 2G | Charcot-Marie-Tooth disease type 2P |
| Autosomal dominant limb girdle muscular dystrophy type 1A | Distal myotilinopathy |
| Autosomal dominant polycystic liver disease | N/A |
| Autosomal recessive combined immunodeficiency with multiple intestinal atresias | N/A |
| B12 deficiency follow-up assessment | B12 deficiency monitoring |
| B12 deficiency initial assessment | B12 deficiency monitoring |
| Bacillus cellulosilyticus | N/A |
| Bacillus chagannorensis | N/A |
| Bacillus coagulans | N/A |
| Bacillus funiculus | N/A |
| Bacillus humi | N/A |
| Bacillus luciferensis | N/A |
| Bacillus mannanilyticus | N/A |
| Bacillus pasteurii | N/A |
| Bacillus pumilus | N/A |
| Bacillus weihenstephanensis | N/A |
| Bacteroides buccae or Bacteroides oris | N/A |
| Banding of bone | N/A |
| Barbiturate analog | Barbiturate |
| Basal anesthetic | Anesthetic |
| Basal ganglia and capsules structure | N/A |
| Beaked whale | N/A |
| Beck-Jianu operation, permanent gastrostomy | Permanent gastrostomy |
| Bedding support | N/A |
| Benign chondrogenic neoplasm of bone and articular cartilage of limb | N/A |
| Benign essential hypertension complicating AND/OR reason for care during puerperium | Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
| Benign neoplasm of ribs and/or sternum and/or clavicle | N/A |
| Benign non-familial neonatal convulsions | Self-limited neonatal epilepsy |
| Benign partial epilepsy of infancy with complex partial seizures | Self-limited familial infantile epilepsy |
| Benign partial epilepsy with secondarily generalized seizures in infancy | Self-limited familial infantile epilepsy |
| Benign tumor of head and neck | N/A |
| Bifidobacterium pseudolongum ss globosum | N/A |
| Bifidobacterium pseudolongum ss pseudolongum | N/A |
| Biguanide oral hypoglycemic agent | Biguanide hypoglycemic agent |
| Bilateral glaucoma of eyes due to plateau iris | N/A |
| Bilateral insertion of drainage tube into anterior chambers | N/A |
| Bimanual phacoemulsification | N/A |
| Biogroup | N/A |
| Birth dislocation of the shoulder | Dislocation of glenohumeral joint due to birth trauma |
| Bismuth biskalcitrate | N/A |
| Blood disorder – follow-up assessment | Blood disorder monitoring |
| Blood disorder – initial assessment | Blood disorder monitoring |
| Blunderbuss pelvis | N/A |
| Bone structure of clavicle and/or scapula and/or humerus | N/A |
| Bone structure of clavicle and/or sternum | N/A |
| Bone structure of rib, sternum and/or clavicle | N/A |
| Borderline blood pressure | N/A |
| Bottle-nosed whale | N/A |
| Bowen’s disease | Squamous cell carcinoma in situ |
| Breast screening abnormal – told patient | Breast neoplasm screening abnormal |
| Bronchography requested | Fluoroscopy of bronchus with contrast requested |
| Butter yaws | N/A |
| Cacao | N/A |
| Callosity caused by prosthesis and/or appliance | Callosity caused by device |
| Candida stellatoidea | N/A |
| Capreocaulus | N/A |
| Carbazepine antiepileptic | Carbamazepine |
| Carbuncle of leg (excluding foot) | N/A |
| Carcinoma of ribs and/or sternum and/or clavicle | N/A |
| Cardiac arrest as a complication of care | Cardiac arrest |
| Cardiac catheter without angiogram | N/A |
| Cardiac enzyme or marker above reference range | N/A |
| Cardiac insufficiency as a complication of care | Heart failure |
| Cardiac markers | N/A |
| Cardiorespiratory failure as a complication of care | N/A |
| Cardiovascular pressure AND/OR pulse finding | N/A |
| Caregiver aware of patient’s feelings about dying | N/A |
| Catheterization for bronchography | N/A |
| Cellulitis of nasal mucous membrane | N/A |
| Cerebral cyst | N/A |
| Cerebral hydatid cyst | N/A |
| Cerebrospinal fluid: protein – increased + | N/A |
| Cerebrospinal fluid: protein – increased ++ | N/A |
| Cerebrovascular and spinal vascular disorders | N/A |
| Charleyhorse | N/A |
| Checking patient identity | Verification of identity |
| Chemical fumes | N/A |
| Chenodeoxycholylglycine, conjugated | N/A |
| Chondrosarcoma grade 1 | N/A |
| Chronic atrophic rhinitis | N/A |
| Chronic disease – follow-up assessment | Chronic disease monitoring |
| Chronic disease – uncooperative patient | N/A |
| Chronic disease initial assessment | Chronic disease monitoring |
| Chronic folliculitis of legs | N/A |
| Chronic hypertension complicating AND/OR reason for care during puerperium | Chronic hypertension in obstetric context |
| Chronic obstructive pulmonary disease follow-up | Chronic obstructive pulmonary disease monitoring |
| Chronic respiratory condition caused by chemical fumes | N/A |
| Cicatricial lagophthalmos | N/A |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for solution for infusion and/or injection vial | N/A |
| Classical | N/A |
| Closed fracture proximal femur, transcervical | N/A |
| Closed injury of digital vein | N/A |
| Closed injury, digital artery | N/A |
| Closed injury, digital vessel, multiple | N/A |
| Closed transcervical fracture of femur | N/A |
| Clostridium butyricum | N/A |
| Clothes washer | N/A |
| Coaxial phacoemulsfication | N/A |
| Collagen glaucoma drainage device | Collagen subconjunctival aqueous humor drainage tube |
| Colostomy enema | N/A |
| Complexion | N/A |
| Complication of breast implant surgery | Disorder of breast implant |
| Complication of implant | Disorder associated with implant |
| Complication of inhalation therapy | Disorder due to inhalation therapy |
| Complication of internal fixation device | Disorder associated with internal fixation device |
| Complication of the puerperium | Disorder of puerperium |
| Complication of ultrasound therapy | Disorder due to ultrasound therapy |
| Component of Apgar score | Neonate observable |
| Confirming patient identity before operative/invasive procedure | N/A |
| Confirming patient identity by direct questioning | Verification of identity by direct questioning |
| Confirming patient identity by guardian interview | Verification of identity using information from guardian |
| Confirming patient identity by wristband | Verification of identity using information on identification band |
| Confirming patient identity prior to procedure | Verification of identity prior to procedure |
| Congenital cerebral cyst | N/A |
| Congenital dystrophia brevicollis | Klippel-Feil sequence |
| Congenital leg bone bowing | N/A |
| Congenital leg length discrepancy | N/A |
| Congenital ridge ear | Congenital deformity of pinna |
| Conjunctival swab taken | Taking conjunctival swab |
| Conjunctival swab taken for virology | Taking conjunctival swab |
| Construction of ear meatus, osseous, skin-lined | N/A |
| Correction of atresia of external meatus of ear | Meatoplasty of external ear |
| Cotton ball | N/A |
| Crag herbicide | Disul-sodium |
| Crandall’s syndrome | Björnstad syndrome |
| Creation of external subdural drain | N/A |
| Cryptogenic Lennox-Gastaut syndrome | Lennox-Gastaut syndrome |
| Cryptogenic West syndrome | Infantile epileptic spasms syndrome |
| Cutis anserina | N/A |
| Cystoscopic insertion of indwelling catheter of ureter | N/A |
| Damage to pelvic joints AND/OR ligaments during delivery | N/A |
| Decerebrate rigidity | N/A |
| Deep vein thrombosis of leg related to air travel | N/A |
| Deficiency of hydroxymethylglutaryl-CoA lyase | N/A |
| Deficiency of inosinase | N/A |
| Deficiency of lecithinase D | N/A |
| Deficiency of lipophosphodiesterase II | N/A |
| Deficiency of long-chain fatty-acyl-CoA hydrolase | N/A |
| Deficiency of pectin methoxylase | N/A |
| Deficiency of pectin methylesterase | N/A |
| Deficiency of retinyl-palmitate esterase | N/A |
| Deficiency of urate oxidase | N/A |
| Degos-Touraine syndrome | N/A |
| Dependent for rising to feet | N/A |
| Desdoxepin | N/A |
| Desmethylparamethadione | N/A |
| Desmethylparamethadione measurement | N/A |
| Destruction of cranial nerve or ganglion | N/A |
| Device applied to patient | Device applied |
| Diabetes mellitus associated with cystic fibrosis | N/A |
| Diabetic – cooperative patient | N/A |
| Diabetic patient unsuitable for digital retinal photography | N/A |
| Diabetic-uncooperative patient | N/A |
| Diencephalic syndrome secondary to tumor | N/A |
| Dietzia cinnamea | N/A |
| Difficulty sitting on toilet | N/A |
| Diffusely infiltrative (linitis plastica) tumor configuration | N/A |
| Digital blood vessel injury | N/A |
| Digitalis | N/A |
| Digitalis only product | N/A |
| Digitalis-containing product | N/A |
| Dihydroxyaluminum aminoacetate | N/A |
| Dimozide | N/A |
| Disarticulation at wrist | N/A |
| Disinfectant | Antiseptic and/or disinfectant |
| Disinfectant causing toxic effect | Poisoning by antiseptic and/or disinfectant |
| Disinfectants and cleansers | Anti-infective agent |
| Disinfectants and cleansers adverse reaction | Anti-infectives adverse reaction |
| Distal loop enema | N/A |
| Diverticulum of duodenum without complication | Diverticulum of duodenum |
| Does not sit on toilet | N/A |
| Does sit on toilet | N/A |
| Dolphin | N/A |
| Drainage of paravesical abscess | N/A |
| Dropping sensation- pelvic floor | Sensation of pelvic floor heaviness |
| Drug addiction counseling | Counseling for substance dependence |
| Drug side effect – acceptable to patient | Willing to accept side effect of medication |
| Drug-induced toxic pustuloderma | N/A |
| Duane anomaly, myopathy, scoliosis syndrome | Horizontal gaze palsy with progressive scoliosis |
| Duration of menstrual period | N/A |
| Dysplastic cortical hyperostosis | N/A |
| Early myoclonic encephalopathy | N/A |
| Easy care weighted disability assessment | N/A |
| Echocardiography for determining interventricular septal thickness | Echocardiography |
| Echocardiography for determining posterior left ventricular wall thickness | Ventricular echocardiography |
| Echocardiography for determining ventricular contraction | Echocardiography |
| Ectopic beats | N/A |
| Effective community coping | N/A |
| Elderly Assessment System | N/A |
| Elderly Assessment System score | N/A |
| Electroshock therapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at the time of procedure | Complication of electroshock therapy |
| Eltor | N/A |
| Emergency visit of patient by chaplain | Emergency pastoral visit |
| Endoscopic catheterization of pancreatic duct and bile duct systems | Endoscopic retrograde cholangiopancreatography |
| Endoscopic catheterization of pancreatic duct system | N/A |
| Endoscopic operation on ureteric orifice | Ureteroscopy |
| Endoscopic retrograde cholangiopancreatography | N/A |
| Endoscopic retrograde cholangiopancreatography with insertion of nasobiliary drainage tube | N/A |
| Endoscopic retrograde cholangiopancreatography with removal of calculus from bile duct | N/A |
| Endoscopic ultrasonography of mediastinum | N/A |
| ENT: follow-up assessment | Ear, nose and throat examination |
| ENT: initial assessment | Ear, nose and throat examination |
| Enteroscopy with video capsule | N/A |
| Entire alveolus dentalis | N/A |
| Entire ampulla coli | N/A |
| Entire basal ganglia and capsules | N/A |
| Entire bone of clavicle and scapula and humerus | N/A |
| Entire bone of rib, sternum and clavicle | N/A |
| Entire Brodmann area 20 | N/A |
| Entire Brodmann area 22 | N/A |
| Entire left sided atrium | N/A |
| Entire nuchal region of neck | N/A |
| Entire oculomotor nerve accessory autonomic nucleus | N/A |
| Entire olivary nucleus | N/A |
| Entire right sided atrium | N/A |
| Entire shoulder joint cavity | N/A |
| Entire spinal cord, roots and ganglia | N/A |
| Entire squamous suture | N/A |
| Entire transcervical section of neck of femur | N/A |
| Entire transverse peduncular tract nucleus | N/A |
| Entire tricuspid valve sub-part | Entire tricuspid valve |
| Entire zygomatic salivary gland | N/A |
| Epidemic acute poliomyelitis | N/A |
| Epilepsy due to Rasmussen syndrome | N/A |
| Epilepsy of infancy with migrating focal seizures | N/A |
| Erythema multiforme due to mycoplasma infection | Erythema multiforme due to Mycoplasma pneumoniae infection |
| Essential hypertension complicating AND/OR reason for care during puerperium | Postpartum pre-existing essential hypertension |
| Etelcalcetide calcium | N/A |
| Evacuation of subdural hematoma | N/A |
| Excision from mesentery | Resection of mesentery |
| Excision of base of skull in posterior cranial fossa | N/A |
| Excision of skin and soft tissue of hand | Excision of skin of hand |
| Excision of skin for graft | N/A |
| Exploration of oral alveolus | N/A |
| Extended left hemihepatectomy | N/A |
| External ear and external auditory canal operations | N/A |
| External ear and external auditory canal procedure | N/A |
| Exuberant cicatrix | N/A |
| Eye swab for virology | Taking eye swab |
| Eye swab sent for C/S | N/A |
| Eye swab taken | Taking eye swab |
| Failed induction of labor | Failed attempted induction of labor |
| Failed mechanical induction | Failed attempted mechanical induction of labor |
| Failed medical induction of labor | Failed attempted medical induction of labor |
| Failure in dose in insulin-shock therapy | N/A |
| Failure of induction of labor by oxytocic drugs | Failed attempted medical induction of labor with oxytocin |
| Failure of orgasm | N/A |
| False hermaphrodite | N/A |
| Familial cervical artery dissection | Isolated spontaneous cervical artery dissection |
| Familial mesial temporal lobe epilepsy with febrile seizures | Genetic epilepsy with febrile seizures plus |
| Familial methemoglobinemia | N/A |
| Female prosthetic urinary bladder outlet collar procedure | N/A |
| Feminizing syndrome of adrenal origin | N/A |
| Fetus with radiation damage | Fetal disorder caused by ionizing radiation |
| Fiberlight anesthetic laryngoscope | Fiberoptic laryngoscope |
| Fibrinolysin | N/A |
| Fibrinolysis – postpartum | Postpartum disorder of abnormal fibrinolysis |
| Fibrositis arm | N/A |
| Finding of duration of menstrual period | N/A |
| Finding related to ability to rise to feet | N/A |
| Finding related to ability to sit on toilet | N/A |
| First encounter by subject | N/A |
| First outpatient appointment date | N/A |
| First postoperative examination and eye dressing | Postoperative examination of eye and application of dressing to eye |
| Flap laceration of leg | N/A |
| Floppy infant syndrome | N/A |
| Fluoroscopic monitoring and radiography for cardiac pacemaker insertion | Fluoroscopy guided insertion of cardiac pacemaker with contrast |
| Fluoroscopy of heart for checking of cardiac pacemaker electrode position | Cardiac fluoroscopy |
| Fluoroscopy of heart for checking of permanent cardiac pacemaker position | Cardiac fluoroscopy |
| Fluoroscopy of heart for checking of position of cardiac monitoring implant position | Cardiac fluoroscopy |
| Follow up substance misuse assessment | Substance misuse monitoring |
| Follow-up cardiac assessment | Cardiac assessment |
| Follow-up diabetic assessment | Diabetic care assessment |
| Follow-up endocrine assessment | Endocrine disorder monitoring |
| Follow-up epilepsy assessment | Epilepsy assessment |
| Follow-up gastrointestinal tract assessment | Evaluation of gastrointestinal tract |
| Follow-up gout assessment | Gout monitoring |
| Follow-up in outpatient clinic | N/A |
| Follow-up neurological assessment | Neurological assessment |
| Follow-up obesity assessment | Obesity monitoring |
| Follow-up ophthalmological assessment | Eye disorder monitoring |
| Follow-up orthopedic assessment | Orthopedic assessment |
| Follow-up ostomy assessment | Ostomy care assessment |
| Follow-up psychiatric assessment | Psychiatric disorder monitoring |
| Follow-up respiratory assessment | Respiratory assessment |
| Follow-up risk drug assessment | High risk drug monitoring |
| Follow-up skin assessment | Skin assessment |
| Follow-up thyroid assessment | Thyroid disease monitoring |
| Follow-up urinary assessment | Urinary disorder monitoring |
| Follow-up warfarin assessment | Warfarin monitoring |
| Forced feeding of patient | Feeding patient |
| Foul smelling urine | N/A |
| FP13 – ex HM forces registrat | N/A |
| FPC acknowledge patient deregistration | N/A |
| FPC told patient deregistered | N/A |
| Fractured nasal septum | N/A |
| Franklinic taste | N/A |
| Frequency of bowel action | N/A |
| Fresh water dolphin | N/A |
| Gasoline fumes | Gasoline vapor |
| General appearance of patient | Finding of general observation of appearance |
| Genetic disorder of lipid storage | N/A |
| Gingival abscess | N/A |
| Glaucoma associated with tumors AND/OR cysts | N/A |
| Glaucoma due to plateau iris | N/A |
| Glaucoma of left eye due to plateau iris | N/A |
| Glaucoma of right eye due to plateau iris | N/A |
| Goodal-Power operation on vagina | N/A |
| Gordon-Taylor hindquarter operation | Amputation of entire lower limb and ipsilateral hemipelvis |
| GP responsibility to patient stopped | N/A |
| Grafting procedure of heart | N/A |
| Granulomatous angiitis of central nervous system | Primary angiitis of central nervous system |
| Gronblad-Strandberg syndrome | N/A |
| Guyon amputation | Amputation of lower limb through tibia and fibula |
| Gynecological disorder: initial assessment | Gynecological disorder monitoring |
| Gynecological follow-up assessment | Gynecological disorder monitoring |
| H/O: procidentia | N/A |
| Healed venous leg ulcer | N/A |
| Heart failure as a complication of care | Heart failure |
| Heide syndrome | Dysplasia with decreased bone density |
| Height below average | Body height below reference range |
| Hemolytic erythrophagocytic syndrome | N/A |
| Hepatic failure as a complication of care | Hepatic failure |
| Hepaticostomy with removal of calculus | N/A |
| Hepatorenal syndrome as a complication of care | Hepatorenal syndrome due to a procedure |
| Hereditary disease in family possibly affecting fetus | N/A |
| Hereditary neuraxial edema | Cerebral edema |
| Hereditary palmoplantar keratoderma Gamborg Nielsen type | Mal de Meleda |
| Histiocytic medullary reticulosis | Omenn syndrome |
| History of abuse | N/A |
| History of domestic abuse | N/A |
| History of domestic emotional abuse | N/A |
| History of domestic physical abuse | N/A |
| History of domestic physical abuse of adult | N/A |
| History of domestic sexual abuse | N/A |
| History of domestic violence | N/A |
| History of emotional abuse | N/A |
| History of nasal sinus surgery | N/A |
| History of physical abuse | N/A |
| History of sexual abuse | N/A |
| History of subdural hematoma | N/A |
| Home visit canceled by patient | N/A |
| Hospital environment | N/A |
| House allergic alveolitis | Hypersensitivity pneumonitis |
| Howarth’s operation | External frontoethmoidectomy |
| Human rubella immunoglobulin | N/A |
| Hyposphagma | N/A |
| Idiopathic non-arteritic ischemic optic neuropathy | N/A |
| Immunization advised | N/A |
| Inadequate preoperative communication with patient | Inadequate preoperative communication |
| Increase in velocity of coronary artery of fetus | Increase in velocity of blood flow of coronary artery of fetus |
| Indication for modification of patient behavior status | N/A |
| Indication for modification of patient cognitive status | N/A |
| Indication for modification of patient emotional status | N/A |
| Indication for modification of patient physical status | N/A |
| Indication for modification of patient psychological status | N/A |
| Indication for modification of patient status | N/A |
| Ineffective community coping | N/A |
| Infantile paralysis | N/A |
| Infection by Capreocaulus | N/A |
| Infection by Schistosoma chestermani | N/A |
| Infection of biventricular cardiac pacemaker | Infection of cardiac resynchronization therapy implantable pacemaker |
| Infection of cardiac graft | N/A |
| Infestation by Neotrombicula | N/A |
| Influenza immunization advised | N/A |
| Influenza immunization advised at home | N/A |
| Influenza immunization advised in surgery | N/A |
| Inguinosuperficial hernia | N/A |
| Initial assessment for clinical trial | Assessment for clinical trial |
| Initial assessment of newborn | Assessment of newborn |
| Initial cardiac assessment | Cardiac assessment |
| Initial diabetic assessment | Diabetic care assessment |
| Initial dilation of female urethra | Dilation of female urethra |
| Initial endocrine assessment | Endocrine disorder monitoring |
| Initial epilepsy assessment | Epilepsy assessment |
| Initial gastrointestinal tract assessment | Evaluation of gastrointestinal tract |
| Initial gout assessment | Gout monitoring |
| Initial neurological assessment | Neurological assessment |
| Initial obesity assessment | Obesity monitoring |
| Initial ophthalmological assessment | Eye disorder monitoring |
| Initial ostomy assessment | Ostomy care assessment |
| Initial patient assessment | General examination of patient |
| Initial prescription of oral contraception | Prescription of oral contraception |
| Initial psychiatric assessment | Psychiatric disorder monitoring |
| Initial respiratory assessment | Respiratory assessment |
| Initial risk drug assessment | High risk drug monitoring |
| Initial skin assessment | Skin assessment |
| Initial substance misuse assessment | Substance misuse monitoring |
| Initial thyroid assessment | Thyroid disease monitoring |
| Initial warfarin assessment | Warfarin monitoring |
| Injury of digital vein | N/A |
| Inpatient counseling by chaplain | Counseling by chaplain |
| Inpatient stay 1 day | N/A |
| Inpatient stay 10 days | N/A |
| Inpatient stay 11 days | N/A |
| Inpatient stay 12 days | N/A |
| Inpatient stay 13 days | N/A |
| Inpatient stay 14 days | N/A |
| Inpatient stay 2 days | N/A |
| Inpatient stay 3 days | N/A |
| Inpatient stay 4 days | N/A |
| Inpatient stay 5 days | N/A |
| Inpatient stay 6 days | N/A |
| Inpatient stay 7 days | N/A |
| Inpatient stay 8 days | N/A |
| Inpatient stay 9 days | N/A |
| Inpatient stay longer than 12 hours | N/A |
| Insect bite to arm – nonvenomous | N/A |
| Insect bite to leg – nonvenomous | N/A |
| Insertion of catheter into esophagus, permanent tube type | N/A |
| Insertion of drainage tube into anterior chamber | N/A |
| Insertion of drainage tube into anterior chamber of left eye | N/A |
| Insertion of drainage tube into anterior chamber of right eye | N/A |
| Insulin shock therapy | N/A |
| Integrity of hymen | N/A |
| Intersexuality | Intersex |
| Intravenous feeding of patient | Parenteral feeding |
| Intubation laryngoscope | N/A |
| Inverse Klippel Trénaunay syndrome | Klippel Trenaunay syndrome |
| Irritant | N/A |
| Isolated angiitis of central nervous system | Primary angiitis of central nervous system |
| Keratodermia tylodes palmaris progressiva | N/A |
| Keratopathy medicamentosa | N/A |
| Lactation tetany | N/A |
| Lactobacillus parakefir | N/A |
| Laparoscopic extended left hemihepatectomy | N/A |
| Late effect of subdural hematoma due to trauma | N/A |
| Left sided atrium | N/A |
| Leg length inequality | N/A |
| Legal blindness | Blindness AND/OR vision impairment level |
| Legal blindness USA | Blindness AND/OR vision impairment level |
| Ligation, division and complete stripping of long and short saphenous veins | N/A |
| Ligation, division and complete stripping of long saphenous veins | N/A |
| Ligation, division and complete stripping of short saphenous veins | N/A |
| Lipid disorder follow up assessment | Lipid disorder monitoring |
| Lipid disorder initial assessment | Lipid disorder monitoring |
| Lives with friends | N/A |
| Localized cranial lesion | N/A |
| Localized supravalvar aortic stenosis at sinutubular junction | N/A |
| Long acting metabolite of methadone | N/A |
| Looks after someone | N/A |
| Lower extremity or both lower extremities | Lower limb structure |
| Lymphedema follow up assessment | Assessment of lymphedema |
| Lysinibacillus manganicus | N/A |
| Male prosthetic urinary bladder outlet collar procedure | N/A |
| Malignant hypertension complicating AND/OR reason for care during puerperium | Malignant hypertension in obstetric context |
| Malignant neoplasm of cerebrum (excluding lobes and ventricles) | Malignant neoplasm of cerebrum |
| Malignant neoplasm of ribs and/or sternum and/or clavicle | N/A |
| Malignant neoplasm of upper lip, lipstick area | N/A |
| Malignant tumor of esophagus, stomach and duodenum | N/A |
| Malignant tumor of lipstick area of lip | N/A |
| Membranous pregnancy | N/A |
| Menopause follow-up assessment | Menopause monitoring |
| Menopause initial assessment | Menopause monitoring |
| Mesonephric cyst | N/A |
| Metabolic function tested | N/A |
| Metastatic malignant neoplasm to skin of shoulder and arm | N/A |
| Methadone analog | N/A |
| Methadone analog adverse reaction | N/A |
| Methadone analog overdose | N/A |
| Methadone analog poisoning | N/A |
| Methadone analog-containing product | N/A |
| Microsporum gypseum | N/A |
| Microwave ablation system probe | N/A |
| Mid frequency deafness | N/A |
| Mineralocorticoid derivative | N/A |
| Miscarriage with complication | Miscarriage |
| Mixed arteriovenous leg ulcer | N/A |
| Monoparesis – arm | Monoparesis of upper limb |
| Mortality prediction model | N/A |
| Mortality prediction model score | N/A |
| Movement | N/A |
| Mucocele of bronchus | N/A |
| Muller-Weiss disease | N/A |
| Multiple congenital cerebral cysts | N/A |
| Multiple liveborn in hospital by vaginal delivery | N/A |
| Multiple liveborn other than twins born in hospital | N/A |
| Myoclonic encephalopathy | Developmental and epileptic encephalopathy |
| Navicular disease | N/A |
| Nephrotic syndrome associated with another disorder | Nephrotic syndrome |
| Nephrotic syndrome with minimal change glomerulonephritis | N/A |
| Neurostimulation procedures of cranial nerve or ganglion | Neurostimulation of cranial nerve |
| New patient questionnaire completed | N/A |
| New patient screening – no abnormality detected | Screening – NAD |
| New patient screening – problem identified | Abnormal finding on screening procedure |
| New patient screening default | N/A |
| New patient screening deleted | N/A |
| New patient screening requested | N/A |
| New patient screening status | Screening status |
| No cardiac failure | N/A |
| No caregiver | N/A |
| No patient name given | N/A |
| No patient sex given | N/A |
| Non-adherent dressing | N/A |
| Nonsurgical reduction of cardiac septum for hypertrophic obstructive cardiomyopathy with angiography of coronary artery | N/A |
| Nonvalved ophthalmic drainage device | Nonvalved subconjunctival aqueous drainage tube with plate |
| Noxious fumes | Fumes |
| Obstetric pelvic joint damage | N/A |
| Obstetric pelvic ligament damage | N/A |
| Occupational allergic contact dermatitis caused by disinfectant | Occupational allergic contact dermatitis caused by antiseptic and/or disinfectant |
| Oceanibulbus | N/A |
| Oculomotor nerve accessory autonomic nucleus | N/A |
| Oligodontia and cancer predisposition syndrome | AXIN2-related attenuated familial adenomatous polyposis |
| Oliguria as a complication of care | Oliguria |
| Olivary nucleus structure | N/A |
| On suspended waiting list | N/A |
| On treatment for hypertension | N/A |
| Open injury, digital artery | N/A |
| Open injury, digital vein | N/A |
| Open injury, digital vessel, multiple | N/A |
| Open reduction of fracture of zygoma or zygomatic arch | N/A |
| Open transcervical fracture of femur | N/A |
| Operation abandoned before onset | N/A |
| Operative choledochoscopy | Choledochoscopy |
| Operative duodenoscopy | Duodenoscopy |
| Operative endoscopy of biliary tract | Biliary tract endoscopy |
| Operative endoscopy of ileum | Endoscopy of ileum |
| Operative endoscopy of jejunum | Endoscopy of jejunum |
| Operative endoscopy of rectum | Proctoscopy |
| Operative endoscopy of small intestine | Enteroscopy |
| Operative enteroscopy | Enteroscopy |
| Operative esophagogastroscopy | Esophagogastroscopy |
| Opioid-induced mood disorder due to opioid abuse | Opioid-induced mood disorder with harmful pattern of opioid use |
| Opioid-induced mood disorder due to opioid dependence | Opioid-induced mood disorder with opioid dependence |
| Ortolani’s test finding | N/A |
| Ostomy patient problem | N/A |
| Otoplasty of auditory canal or meatus | N/A |
| Outpatient counseling by chaplain | Counseling by chaplain |
| Paenibacillus jamilae | N/A |
| Painful ophthalmoplegia | N/A |
| Paratyphoid fever vaccination | Administration of typhoid vaccine |
| Paratyphoid vaccine | Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product |
| Partial excision | Excision |
| Partner unable to care for subject | Partner unable to provide care |
| Past pregnancy history of complication of puerperium | Past pregnancy history of disorder of puerperium |
| Pasteurella lymphangitidis | N/A |
| Patient “re-called”-prevention | N/A |
| Patient address unknown | N/A |
| Patient asked to attend | N/A |
| Patient asked to make an appointment | N/A |
| Patient awaiting domiciliary | N/A |
| Patient awaiting equipment | N/A |
| Patient awaiting investigation | N/A |
| Patient awaiting medical adm | N/A |
| Patient awaiting outpatient department appointment | N/A |
| Patient awaiting procedure | N/A |
| Patient awaiting surgical adm | N/A |
| Patient away at college or university | N/A |
| Patient away at school | N/A |
| Patient breast aware | Has breast awareness |
| Patient comes 2 monthly | N/A |
| Patient comes 3 monthly | N/A |
| Patient comes 6 monthly | N/A |
| Patient comes monthly | N/A |
| Patient comes more than once a month | N/A |
| Patient comes more than once a week | N/A |
| Patient comes yearly | N/A |
| Patient concerned about eyesight | Concern about eyesight |
| Patient consented to clinical trial | Consent given for clinical trial participation |
| Patient defaulted from follow-up | N/A |
| Patient deregistered by GP | N/A |
| Patient deregistration status | N/A |
| Patient dissatisfied with nutrition regime | Dissatisfaction with nutrition regime |
| Patient distance to surgery unknown | N/A |
| Patient DOB unknown | N/A |
| Patient does not understand why taking all medication | Does not understand reason for medication |
| Patient eligible for clinical trial | Eligible for clinical trial |
| Patient entered into trial | Entered into clinical trial |
| Patient forename unknown | N/A |
| Patient forgets to take medication | Forgets to take medication |
| Patient given choice of treatment | Given choice of treatment |
| Patient has gone abroad | N/A |
| Patient has moved away | N/A |
| Patient has private medical insurance | N/A |
| Patient hospital number unknown | N/A |
| Patient identification | Verification of identity |
| Patient identity verified | Verification of identity completed |
| Patient in asthma study | Participating in clinical research study on asthma |
| Patient in head down position | Trendelenburg position |
| Patient in head up position | Inverse Trendelenburg position |
| Patient in heart disease study | Participating in clinical research study on heart disease |
| Patient in heart study | Participating in clinical research study on heart disease |
| Patient in lateral position for intubation | Lateral decubitus position |
| Patient in local study | Participating in clinical research study |
| Patient in room | N/A |
| Patient in semi-recumbent position | Semi-recumbent position |
| Patient in supine position with hip support | Supine position with hip support |
| Patient marital status unknown | N/A |
| Patient may not register | N/A |
| Patient misunderstood treatment instructions | Misunderstood treatment regime instructions |
| Patient never seen | N/A |
| Patient not on medication | N/A |
| Patient not on self-medication | Is not self-medicating |
| Patient not registered | N/A |
| Patient not registered with dentist | N/A |
| Patient not seen for more than five years | N/A |
| Patient not seen for more than one year | N/A |
| Patient occupation unknown | N/A |
| Patient on circulatory assist | Circulatory assistance device in situ |
| Patient on intra-aortic balloon pump assist | Intra-aortic balloon pump in situ |
| Patient on maximal tolerated angiotensin converting enzyme inhibitor therapy | On maximum tolerated dose of angiotensin converting enzyme inhibitor therapy |
| Patient on maximal tolerated angiotensin II receptor antagonist therapy | On maximum tolerated dose of angiotensin II receptor antagonist therapy |
| Patient on maximal tolerated anticonvulsant therapy | On maximum tolerated dose of anticonvulsant therapy |
| Patient on maximal tolerated antihypertensive therapy | On maximum tolerated dose of antihypertensive therapy |
| Patient on maximal tolerated beta blocker therapy | On maximum tolerated dose of beta blocker therapy |
| Patient on maximal tolerated lipid lowering therapy | On maximum tolerated dose of lipid lowering therapy |
| Patient on maximal tolerated therapy for diabetes | On maximum tolerated dose of medication for diabetes mellitus |
| Patient on maximum tolerated dose | On maximum tolerated dose |
| Patient on numerous drugs | Polypharmacy |
| Patient on oxygen | On oxygen therapy |
| Patient on self-medication | Is self-medicating |
| Patient on waiting list | Waiting list status |
| Patient position for regional block | Body position finding |
| Patient position for tracheal intubation | Body position finding |
| Patient position with extension of head | Extension of head position |
| Patient position with flexion of neck | Neck flexion |
| Patient post-code unknown | N/A |
| Patient reg. form sent to HB | N/A |
| Patient registered | N/A |
| Patient registered – FP1 | N/A |
| Patient registered – FP106 | N/A |
| Patient registered – FP13 | N/A |
| Patient registered – FP19 | N/A |
| Patient registered – FP32 | N/A |
| Patient registered – FP4 | N/A |
| Patient registered – FP4/4B | N/A |
| Patient registered – FP58 | N/A |
| Patient registered – GPR | N/A |
| Patient registered by FPC | N/A |
| Patient registered GMS1 | N/A |
| Patient registration – data queries | N/A |
| Patient registration data status | N/A |
| Patient registration data unknown | N/A |
| Patient registration-form used | N/A |
| Patient requests alternative treatment | Request for alternative treatment |
| Patient requests non-blood medical management | Requests treatment does not include administration of blood products |
| Patient re-registered | N/A |
| Patient says leaving list | N/A |
| Patient seen only once | N/A |
| Patient sex unknown | N/A |
| Patient signed registration form | N/A |
| Patient surname unknown | N/A |
| Patient telephone number unknown | N/A |
| Patient title unknown | N/A |
| Patient told by GP deregistered | N/A |
| Patient treated with medication | Treatment given |
| Patient unable to bite with denture | Unable to bite with denture |
| Patient unable to chew with denture | Unable to chew with denture |
| Patient unable to chew with orthodontic appliance | Unable to chew with orthodontic appliance |
| Patient unable to eat with denture | Unable to eat with denture |
| Patient unable to eat with orthodontic appliance | Unable to eat with orthodontic appliance |
| Patient unable to wear denture | Unable to wear denture |
| Patient unable to wear maxillofacial prosthesis | Unable to wear maxillofacial prosthesis |
| Patient unable to wear orthodontic appliance | Unable to wear orthodontic appliance |
| Patient understands why taking all medication | Does understand reason for medication |
| Patient unhappy with medication regime | Dissatisfaction with medication regime |
| Patient unsuitable for procedure | Not suitable for procedure |
| Patient unsuitable for procedure due to age | Not suitable for procedure due to age |
| Patient unsuitable for procedure due to medical condition | Not suitable for procedure due to disease |
| Patient unsuitable for procedure due to psychological condition | Not suitable for procedure due to mental disorder |
| Patient ventilated | On artificial ventilation |
| Patient withdrawn from trial | Withdrawn from clinical trial |
| Patient works away | N/A |
| Pattee operation on auditory canal | Reconstruction of external auditory canal |
| Pelvic joint/ligament damage | N/A |
| Pentamidine diisothionate | N/A |
| Percutaneous transluminal septal myocardial ablation | N/A |
| Periarticular bone structure of shoulder joint | N/A |
| Peritoneal lavage, initial | Peritoneal lavage |
| Phlebitis as a complication of care | Phlebitis |
| Phoma eupyvera | N/A |
| Piriform sclerosis of ilium | N/A |
| Plateau iris | N/A |
| Plateau iris of bilateral eyes | N/A |
| Plateau iris of left eye | N/A |
| Plateau iris of right eye | N/A |
| Poisoning caused by Digitalis | N/A |
| Porpoise | N/A |
| Post paratyphoid vaccination encephalitis | Encephalitis caused by typhoid vaccine |
| Post-immunization arthritis | N/A |
| Post-immunization encephalitis | N/A |
| Post-immunization myelitis | N/A |
| Postinfective arthropathy caused by fungus | Fungal arthritis |
| Postoperative paralytic ileus | N/A |
| Postpartum state, 7 weeks | Postnatal data |
| Postpartum state, 8 weeks | Postnatal data |
| Postpartum state, 9 weeks | Postnatal data |
| PPP2R5D-related intellectual disability | N/A |
| Presence of interpreter | Finding related to presence of interpreter |
| Presentation of prolapsed arm of fetus | N/A |
| Preston | N/A |
| Primary carcinoma of ribs and/or sternum and/or clavicle | N/A |
| Primary glaucoma due to combination of mechanisms | Glaucoma due to combination of mechanisms |
| Primary malignant neoplasm of ribs and/or sternum and/or clavicle | N/A |
| Primary open reduction of fracture and internal fixation with tension band wiring | Open reduction of fracture and internal fixation with tension band wiring |
| Primary open reduction of fracture of patella and fixation with tension band wiring | Open reduction of fracture of patella and fixation with tension band wiring |
| Private home delivery booking | N/A |
| Progressive sensory ataxia of Charolais | N/A |
| Prolapse of gravid uterus | N/A |
| Prophyllin | N/A |
| Protein secretory trypsin inhibitor | N/A |
| Pseudallescheria boydii | N/A |
| Pseudomonas pseudoalcaligenes | N/A |
| Pseudomonas pseudoalcaligenes ss pseudoalcaligenes | N/A |
| Pseudopropionibacterium | N/A |
| Pseudopropionibacterium propionicum | N/A |
| Pyogenic bacterium | Domain Bacteria |
| Questionable if distance from patient home to site of care correct | N/A |
| Questionable if first name of patient correct | N/A |
| Questionable if last name of patient correct | N/A |
| Questionable if patient address correct | N/A |
| Questionable if patient date of birth correct | N/A |
| Questionable if patient hospital number correct | N/A |
| Questionable if patient marital status correct | N/A |
| Questionable if patient occupation correct | N/A |
| Questionable if patient postal code correct | N/A |
| Questionable if patient sex correct | N/A |
| Questionable if patient telephone number correct | N/A |
| Questionable if patient title correct | N/A |
| Radiofrequency destruction of nerves and ganglia | N/A |
| Radionuclide cardiac study for detection of right to left lung shunt | Radionuclide cardiac shunt study |
| Ready for enhanced community coping | N/A |
| Recoarctation of aorta | N/A |
| Reduction and reconstruction of craniomegalic skull | N/A |
| Reduction and reconstruction of craniomegalic skull with craniotomy | N/A |
| Reduction of batwing arms | N/A |
| Reduction of buttocks | N/A |
| Reduction of ciliary body | N/A |
| Reduction of nasal turbinate | N/A |
| Reduction of Reinke’s edema | N/A |
| Reduction of size of abdominal wall | N/A |
| Referral of patient to parish chaplain for follow-up care | Referral to pastoral care provider |
| Refetoff syndrome | N/A |
| Refractory infantile spasms | Infantile epileptic spasms syndrome |
| Regional enteritis of the jejunum | Crohn’s disease of jejunum |
| Registered for access to online patient education | N/A |
| Registered in deprived area | N/A |
| Registered in deprived area – high | N/A |
| Registered in deprived area – low | N/A |
| Registered in deprived area – medium | N/A |
| Regular monitoring discussed with patient | Medication monitoring discussed |
| Relative afferent pupil defect | N/A |
| Relatives unable to care for patient | Family unable to provide care |
| Removal of foreign body from alveolus | N/A |
| Renal failure as a complication of care | Renal failure syndrome |
| Renewal of external subdural drain | N/A |
| Repeat prescription – follow-up assessment | Repeat prescription monitoring |
| Repeat prescription – initial assessment | Repeat prescription monitoring |
| Replantation of whole arm | N/A |
| Retinyl-palmitate esterase | N/A |
| Retrograde urography without KUB | N/A |
| Revision of external subdural drain | Replacement of external drain in subdural space |
| Rh negative Du positive | Weak D phenotype |
| Rheumatoid arthritis with vasculitis | N/A |
| Rheumatology follow-up assessment | Rheumatology disorder monitoring |
| Rheumatology initial assessment | Rheumatology disorder monitoring |
| Rhodococcus baikonurensis | N/A |
| Rhodococcus imtechensis | N/A |
| Rhodococcus percolatus | N/A |
| Rhodococcus qingshengii | N/A |
| Rhodotorula pilimanae | N/A |
| Right sided atrium | N/A |
| Riley-Shwachman syndrome | N/A |
| Route of medication administration not appropriate for patient | Route of medication administration not appropriate |
| Routine visit of patient by chaplain | Pastoral visit |
| Sarcoid arthropathy | N/A |
| Schistosoma chestermani | N/A |
| Schoepf-Schulz-Passage syndrome | Schöpf-Schulz-Passarge syndrome |
| Shock therapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at the time of procedure | Complication of electroshock therapy |
| Shoulder joint cavity | N/A |
| Sialoangiitis | N/A |
| Simple repair of hypospadias complications | N/A |
| Single congenital cerebral cyst | N/A |
| Sinus | N/A |
| Sleep finding | N/A |
| Small intestine endoscopy | N/A |
| Sodium-n-methyl dithiocarbamate | N/A |
| Spasmodic dysmenorrhea | N/A |
| Spasmus nictitans | Excessive blinking – involuntary |
| Sperm whale | N/A |
| Sphingobium japonicum | N/A |
| Spinal cord, roots and ganglia structure | N/A |
| Spinal epiphysiopathy | N/A |
| Splinter of abdominal wall without major open wound, infected | Splinter in abdominal wall with infection |
| Splinter of abdominal wall, without major open wound | Splinter in abdominal wall |
| Splinter of ankle, without major open wound, infected | Splinter in ankle with infection |
| Splinter of anus, without major open wound | Splinter in anus |
| Splinter of axilla, without major open wound | Splinter in axilla |
| Splinter of axilla, without major open wound, infected | Splinter in axilla with infection |
| Splinter of back without major open wound, infected | Splinter in back with infection |
| Splinter of back, without major open wound | Splinter in back |
| Splinter of breast without major open wound, infected | Splinter in breast with infection |
| Splinter of breast, without major open wound | Splinter in breast |
| Splinter of buttock without major open wound, infected | Splinter in buttock with infection |
| Splinter of buttock, without major open wound | Splinter in buttock |
| Splinter of chest wall without major open wound, infected | Splinter in chest wall with infection |
| Splinter of chest wall, without major open wound | Splinter in chest wall |
| Splinter of elbow, without major open wound | Splinter in elbow |
| Splinter of elbow, without major open wound, infected | Splinter in elbow with infection |
| Splinter of face, without major open wound | Splinter in face |
| Splinter of face, without major open wound, infected | Splinter in face with infection |
| Splinter of finger, without major open wound, infected | Splinter in finger with infection |
| Splinter of flank without major open wound, infected | Splinter in flank with infection |
| Splinter of flank, without major open wound | Splinter in flank |
| Splinter of foot and toe, without major wound, infected | N/A |
| Splinter of foot, without major open wound | Splinter in foot |
| Splinter of foot, without major open wound, infected | Splinter in foot with infection |
| Splinter of forearm, without major open wound | Splinter in forearm |
| Splinter of groin without major open wound, infected | Splinter in groin with infection |
| Splinter of groin, without major open wound | Splinter in groin |
| Splinter of hand, without major open wound, infected | Splinter in hand with infection |
| Splinter of head, without major open wound, infected | Splinter in head with infection |
| Splinter of hip, without major open wound | Splinter in hip |
| Splinter of hip, without major open wound, infected | Splinter in hip with infection |
| Splinter of interscapular region without major open wound, infected | Splinter in interscapular region with infection |
| Splinter of interscapular region, without major open wound | Splinter in interscapular region |
| Splinter of knee, without major open wound | Splinter in knee |
| Splinter of knee, without major open wound, infected | Splinter in knee with infection |
| Splinter of lower arm, without major open wound, infected | Splinter in forearm with infection |
| Splinter of lower leg, without major open wound | Splinter in lower leg |
| Splinter of lower leg, without major open wound, infected | Splinter in lower leg with infection |
| Splinter of lower limb, without major open wound, infected | Splinter in lower limb with infection |
| Splinter of neck, without major open wound | Splinter in neck |
| Splinter of neck, without major open wound, infected | Splinter in neck with infection |
| Splinter of penis without major open wound, infected | Splinter in penis with infection |
| Splinter of penis, without major open wound | Splinter in penis |
| Splinter of perineum without major open wound, infected | Splinter in perineum with infection |
| Splinter of perineum, without major open wound | Splinter in perineum |
| Splinter of scalp, without major open wound | Splinter in scalp |
| Splinter of scalp, without major open wound, infected | Splinter in scalp with infection |
| Splinter of scapular region, without major open wound | Splinter in scapular region |
| Splinter of scapular region, without major open wound, infected | Splinter in scapular region with infection |
| Splinter of scrotum and testis without major open wound, infected | Splinter in scrotum and testis with infection |
| Splinter of scrotum and testis, without major open wound | Splinter in scrotum and testis |
| Splinter of shoulder and upper arm, without major wound, infected | N/A |
| Splinter of shoulder, without major open wound | Splinter in shoulder |
| Splinter of shoulder, without major open wound, infected | Splinter in shoulder with infection |
| Splinter of thigh, without major open wound | Splinter in thigh |
| Splinter of thigh, without major open wound, infected | Splinter in thigh with infection |
| Splinter of toe, without major open wound | Splinter in toe |
| Splinter of toe, without major open wound, infected | Splinter in toe with infection |
| Splinter of trunk without major open wound, infected | Splinter in trunk with infection |
| Splinter of upper arm, without major open wound | Splinter in upper arm |
| Splinter of upper arm, without major open wound, infected | Splinter in upper arm with infection |
| Splinter of vagina without major open wound, infected | Splinter in vagina with infection |
| Splinter of vagina, without major open wound | Splinter in vagina |
| Splinter of vulva without major open wound, infected | Splinter in vulva with infection |
| Splinter of vulva, without major open wound | Splinter in vulva |
| Splinter of wrist, without major open wound | Splinter in wrist |
| Splinter of wrist, without major open wound, infected | Splinter in wrist with infection |
| Spouse unable to care for patient | Spouse unable to provide care |
| Squamous suture structure | N/A |
| Standardized assessment of personality | Standardised Assessment of Personality – Abbreviated Scale |
| Straining | N/A |
| Streptomyces canescens | N/A |
| Streptomyces champavatii | N/A |
| Streptomyces coelicolor | N/A |
| Streptomyces felleus | N/A |
| Streptomyces globisporus subspecies caucasicus | N/A |
| Streptomyces griseus solvifaciens | N/A |
| Streptomyces limosus | N/A |
| Streptomyces odorifer | N/A |
| Streptomyces sampsonii | N/A |
| Stromal pigmentation | N/A |
| Structure of alveolus dentalis | N/A |
| Structure of Brodmann area 20 of inferior temporal gyrus | N/A |
| Structure of Brodmann area 22, superior temporal | N/A |
| Structure of layer of uterine wall | Structure of layer of wall of body of uterus |
| Structure of nuchal region of neck | N/A |
| Structure of transcervical section of neck of femur | N/A |
| Structure of transverse peduncular tract nucleus | N/A |
| Subsequent encounter by subject | N/A |
| Substance use prevention | N/A |
| Surgical approach | Procedure approach |
| Surgical reduction | N/A |
| Suspected elder abuse | N/A |
| Suspected fetal damage from radiation | Fetal disorder caused by ionizing radiation suspected |
| Suspected mental condition not found | N/A |
| Symptomatic form of fragile X syndrome in female carrier | N/A |
| Symptomatic Lennox-Gastaut syndrome | Lennox-Gastaut syndrome |
| Symptomatic West syndrome | Infantile epileptic spasms syndrome |
| SYNGAP1-related intellectual disability | SYNGAP1-related developmental and epileptic encephalopathy |
| Syntocinon induction of labor | Oxytocin induction of labor |
| Tendinitis of elbow or forearm | N/A |
| Thick film for malarial parasites | N/A |
| Thigh reduction | N/A |
| Thrombocytopenia due to extracorporeal circulation of blood | N/A |
| Thrombosis transverse sinus | N/A |
| Tinea profunda | N/A |
| Toothed whale | N/A |
| Topical anesthetic | Local anesthetic |
| Torsional phacoemulsification | N/A |
| Trauma to perineum and/or vulva during delivery | N/A |
| Trichophyton ajelloi | N/A |
| Trichophyton ajelloi var. ajelloi | N/A |
| Trichurus | N/A |
| Tropical phagedenic ulcer of leg | N/A |
| True yeast | Saccharomycetales |
| Tsukamurella sunchonensis | N/A |
| Tuffier operation for vaginal hysterectomy | N/A |
| Tumor invasion into muscle layer | N/A |
| Tumor of nasopharyngeal floor | N/A |
| TUR syndrome | N/A |
| Tyrosinemia | N/A |
| Ultrasonography of cardiac ventricle for resynchronization | Ventricular echocardiography |
| Ultrasound scan – multiple fetus | N/A |
| Unable to sit on toilet | N/A |
| Upper respiratory inflammation caused by chemical fumes | N/A |
| Urban operation, extended radical mastectomy | Extended radical mastectomy |
| Urinary: initial assessment | Urinary disorder monitoring |
| Urine: dark/concentrated | Urine looks dark |
| US scan of joints of foot | N/A |
| Uses intrauterine contraception | N/A |
| Values (community) | N/A |
| Valved ophthalmic drainage device | Valved subconjunctival aqueous drainage tube with plate |
| Varicose veins of the leg with eczema | N/A |
| Varicose veins of the leg with rupture | N/A |
| Vascormone | N/A |
| Vasculitis of systemic vasculature | Vasculitis |
| Venous measurement – finding | Venous finding |
| Virgo intacta | N/A |
| Virgo intacta – contraception unnecessary | N/A |
| Visit of dying patient by chaplain | End of life pastoral visit |
| Visit of patient by chaplain | Pastoral visit |
| Visit of patient by chaplain during palliative care | End of life pastoral visit |
| Visit of patient by chaplain in emergency room | Pastoral visit |
| Visit of patient by chaplain in intensive care | Pastoral visit |
| Visit of patient by chaplain prior to surgery | Pastoral visit |
| West syndrome | Infantile epileptic spasms syndrome |
| Whale | N/A |
| Williams-Richardson operation for construction of vagina | N/A |
| Xanthomonas cynarae | N/A |
| Xiphodynia | N/A |
| X-linked intellectual disability Brooks type | Juberg Marsidi syndrome |
| Zygomatic salivary gland | N/A |